Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 1758383, 9 pages
https://doi.org/10.1155/2018/1758383
Research Article

Bushenkangshuai Tablet Reduces Atherosclerotic Lesion by Improving Blood Lipids Metabolism and Inhibiting Inflammatory Response via TLR4 and NF-κB Signaling Pathway

1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
2Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
3Medical College, Xiamen University, Xiamen 361102, China

Correspondence should be addressed to Li Peng; moc.liamtoh@564gnepp and Jun-ping Zhang; moc.liamtoh@mcthz

Received 4 August 2017; Revised 6 November 2017; Accepted 10 December 2017; Published 24 January 2018

Academic Editor: Gorkem Kismali

Copyright © 2018 Shu-chao Pang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Shu-chao Pang, Li Peng, Jun-ping Zhang, et al., “Bushenkangshuai Tablet Reduces Atherosclerotic Lesion by Improving Blood Lipids Metabolism and Inhibiting Inflammatory Response via TLR4 and NF-κB Signaling Pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2018, Article ID 1758383, 9 pages, 2018. https://doi.org/10.1155/2018/1758383.